These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cell-mediated immune response to human immunodeficiency virus in homosexual men. Ranki A J Infect Dis; 1993 Feb; 167(2):498. PubMed ID: 8421190 [No Abstract] [Full Text] [Related]
4. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope. Emini EA; Koff WC Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131 [No Abstract] [Full Text] [Related]
5. Can immune responses to human immunodeficiency virus be preserved, enhanced, or restored? Walker BD AIDS Clin Rev; 2000-2001; ():101-14. PubMed ID: 10999218 [No Abstract] [Full Text] [Related]
6. Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men. Krohn K; Robey WG; Putney S; Arthur L; Nara P; Fischinger P; Gallo RC; Wong-Staal F; Ranki A Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4994-8. PubMed ID: 2440037 [TBL] [Abstract][Full Text] [Related]
7. Can immune systems be trained to fight HIV? Balter M Science; 1999 Nov; 286(5444):1470-11. PubMed ID: 10610544 [No Abstract] [Full Text] [Related]
8. Immunology of HIV infection. Lewis DE; Giorgi JV Int Rev Immunol; 1990; 7(1):1-13. PubMed ID: 1983450 [TBL] [Abstract][Full Text] [Related]
9. In vitro selection of HIV and CMV specific T-lymphocytes. Li Pira G; Bottone L; Ivaldi F; Ricciardi A; Barbano G; Manca F J Biol Regul Homeost Agents; 2004; 18(2):183-6. PubMed ID: 15471225 [TBL] [Abstract][Full Text] [Related]
10. T-cell strategies in AIDS vaccines: MHC-restricted T-cell responses to HIV proteins. Mills KH; Nixon DF; McMichael AJ AIDS; 1989; 3 Suppl 1():S101-10. PubMed ID: 2575396 [No Abstract] [Full Text] [Related]
11. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1. Rivière Y Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():45-8. PubMed ID: 7950861 [TBL] [Abstract][Full Text] [Related]
12. The immunopathogenesis of HIV infection. Rosenberg ZF; Fauci AS Adv Immunol; 1989; 47():377-431. PubMed ID: 2573256 [No Abstract] [Full Text] [Related]
13. Resistance of HIV-infected cells to cytotoxic T lymphocytes. Collins KL Microbes Infect; 2004 Apr; 6(5):494-500. PubMed ID: 15109965 [TBL] [Abstract][Full Text] [Related]
14. Protection from HIV infection or AIDS? Miedema F; Meyaard L; Klein MR Science; 1993 Nov; 262(5136):1074-6. PubMed ID: 8235627 [No Abstract] [Full Text] [Related]
16. Modification of the immune response against hepatitis B virus by the human immunodeficiency virus. Hess G; Rossol S; Voth R; Weber KC; Meyer zum Büschenfelde KH Rheumatol Int; 1989; 9(3-5):175-9. PubMed ID: 2532781 [TBL] [Abstract][Full Text] [Related]
17. The CD4 antigen: physiological ligand and HIV receptor. Sattentau QJ; Weiss RA Cell; 1988 Mar; 52(5):631-3. PubMed ID: 2830988 [No Abstract] [Full Text] [Related]
18. Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev. Blazevic V; Ranki A; Krohn KJ AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1335-42. PubMed ID: 8573390 [TBL] [Abstract][Full Text] [Related]
19. [Prognostic indices for the course of HIV infection]. Hess G Verh Dtsch Ges Inn Med; 1991; 97():386-90. PubMed ID: 1687300 [No Abstract] [Full Text] [Related]